JAMES C YAO

Concepts (643)

Concepts are derived automatically from a person's publications.
The timeline below shows the dates (blue tick marks) of publications associated with JAMES C YAO's top concepts. The average publication date for each concept is shown as a red circle, illustrating changes in the primary topics that JAMES C YAO has written about over time.
Carcinoma, Islet Cell, 5 publications between 2004 and 2008, average publication date November 2006. Stomach Neoplasms, 43 publications between 1999 and 2023, average publication date February 2007. Carcinoid Tumor, 25 publications between 2003 and 2017, average publication date January 2009. TOR Serine-Threonine Kinases, 15 publications between 2007 and 2017, average publication date September 2010. Sirolimus, 15 publications between 2008 and 2013, average publication date March 2011. Antineoplastic Combined Chemotherapy Protocols, 41 publications between 2000 and 2023, average publication date June 2011. Insulinoma, 7 publications between 2007 and 2019, average publication date July 2011. Clinical Trials, Phase II as Topic, 7 publications between 2007 and 2015, average publication date September 2011. Pancreatic Neoplasms, 56 publications between 2004 and 2022, average publication date December 2012. Antineoplastic Agents, Hormonal, 12 publications between 1999 and 2021, average publication date July 2013. Carcinoma, Neuroendocrine, 13 publications between 2007 and 2024, average publication date September 2013. Octreotide, 21 publications between 2008 and 2021, average publication date November 2013. Antineoplastic Agents, 36 publications between 1999 and 2021, average publication date November 2013. Gastrointestinal Neoplasms, 23 publications between 2007 and 2021, average publication date March 2014. Bevacizumab, 12 publications between 2007 and 2022, average publication date March 2014. Neuroendocrine Tumors, 107 publications between 2005 and 2024, average publication date May 2014. Liver Neoplasms, 26 publications between 2003 and 2024, average publication date October 2014. Everolimus, 33 publications between 2008 and 2021, average publication date February 2015. Clinical Trials, Phase III as Topic, 9 publications between 2008 and 2021, average publication date June 2015. Malignant Carcinoid Syndrome, 11 publications between 2011 and 2021, average publication date March 2016.

To see the data from this visualization as text, click here.
YAO's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (643)
Explore
_
Co-Authors (164)
Explore
_
Similar People (60)
Explore
_
Same Department Expand Description
Explore
_